Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Hannah, Woopen"'
Autor:
Jalid Sehouli, Kristina Mueller, Rolf Richter, Markus Anker, Hannah Woopen, Julia Rasch, Jacek P. Grabowski, Eva Prinz‐Theissing, Melisa Guelhan Inci
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 12, Iss 2, Pp 393-402 (2021)
Abstract Background Malnutrition and sarcopenia often occur simultaneously in cancer patients and are thought to have harmful effects on both surgical and oncological outcomes. Therefore, we want to evaluate the effects of sarcopenia and malnutrition
Externí odkaz:
https://doaj.org/article/53cbff2c5a684828ac34c82c6c496ec3
Autor:
Jacek Grabowski, Ioana Elena Braicu, Edgar Petru, Hannah Woopen, Andreas Müller, Yasemin Virk, Gerhard Bogner, Manfred Hensel, Dario Zocholl, Holm Eggemann, Christian Marth, Mateja Condic, Christian Dannecker, Dorothea Fischer, Jalid Sehouli
Publikováno v:
Ovarian cancer.
Autor:
Nina Buttmann-Schweiger, Klaus Pietzner, Klaus Kraywinkel, Hannah Woopen, Benjamin Barnes, Carolin Rolf, Joanna Baum, Elena Ioana Braicu, Jalid Sehouli
Publikováno v:
International Journal of Gynecologic Cancer. 31:709-712
ObjectiveTo evaluate the rate of secondary malignancies in long-term survivors with ovarian cancer.MethodsLong-term survivors with ovarian cancer (survival ≥8 years after initial diagnosis) with multiple malignancies were identified within the Tumo
Autor:
Hannah Woopen, Jalid Sehouli, Kathrin Heise, Melisa Guelhan Inci, Louise Anders, Rolf Richter
Publikováno v:
Archives of Gynecology and Obstetrics
Purpose The aim of this study was to investigate preoperative quality of life (QoL) as a predictive tool for severe postoperative complications (POC) in gynecological cancer surgery. Methods This is a prospective study of patients undergoing gynecolo
Autor:
Mirza, Nicoletta Colombo, Giovanni Scambia, Dominik Denschlag, Hannah Woopen, Florian Heitz, P. Wimberger, Werner Meier, Jalid Sehouli, Ana Oaknin, J. W. Kim, A. du Bois, Jacobus Pfisterer, Michael Eichbaum, S Spiegelberg, I.L. Ray-Coquard, Kristina Lindemann, P. Harter, D Tutschkow, Anne Floquet
Publikováno v:
Ovarian cancer.
Introduction/Background* There is poor evidence from mostly retrospective series whether co-medication with metformin, statin or beta-blocker have an impact on survival in patients with primary ovarian cancer. The aim of this study was to investigate
Autor:
Pauline Wimberger, Jalid Sehouli, J Grabowksi, Radoslav Chekerov, Matthias Endres, A Relógio, Elena-Ioana Braicu, C Scheibenbogen, Hannah Woopen, J Gerber, Michael Eichbaum, M Deryal, J Dysarz, Matthias Rose
Publikováno v:
Ovarian cancer.
Introduction/Background* Ovarian cancer (OC) is associated with the highest mortality rates among gynecological malignancies, with most patients being diagnosed in advanced stages. The most common histological subtype is high grade serous OC, which i
Autor:
Radoslav Chekerov, Rolf Richter, S Alavi, G Inci, Jacek P. Grabowski, Hannah Woopen, Jalid Sehouli
Publikováno v:
Supportive Care in Cancer. 28:73-78
The aim of this study was to analyze the potential impact of chemotherapy-induced nausea and vomiting (CINV) on dose reductions, discontinuation of chemotherapy, and survival. This study was designed as individual participant data meta-analysis with
Publikováno v:
ESMO Open
Objective Recurrent ovarian cancer is an incurable disease with variable but poor prognosis. Health-related quality of life (HRQoL) is a patient-reported outcome measure generally applied to measure effects of therapies. Our aim was the development a
Autor:
Melisa Guelhan Inci, Rolf Richter, Kathrin Heise, Ricarda Dukatz, Hannah Woopen, Jalid Sehouli
Publikováno v:
Cancers
Volume 13
Issue 4
Cancers, Vol 13, Iss 631, p 631 (2021)
Volume 13
Issue 4
Cancers, Vol 13, Iss 631, p 631 (2021)
Introduction: The aim of this analysis was to evaluate the health-related quality of life (HR-QoL) in patients with ovarian cancer using a patient-reported outcome (PRO) based questionnaire and to compare it to the healthy female population in German
Autor:
Bogdan Fetica, Pierluigi Benedetti Panici, Silvia Darb-Esfahani, Sven Mahner, Ilary Ruscito, Els Van Nieuwenhuysen, Maria Luisa Gasparri, Joanna Baum, Aarne Feldheiser, Adriaan Vanderstichele, Michael D. Mueller, Elena Ioana Braicu, Ignace Vergote, Jalid Sehouli, Hannah Woopen, Andrea Papadia, Linn Wölber, Nicole Concin, A Berger, Oliver Hunsicker, Patriciu Achimas-Cadariu
IntroductionLong-term survivors of ovarian cancer are a unique group of patients in whom prognostic factors for long-term survival have been poorly described. Such factors may provide information for a more personalized therapeutic approach. The obje
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53418d2fc759d6514c112171e401367f
http://hdl.handle.net/11573/1510320
http://hdl.handle.net/11573/1510320